Rheumatoid arthritis and anti-CCP
| dc.contributor.author | Yousif Osman | |
| dc.contributor.author | Shaaban Khudair | |
| dc.contributor.author | Ahmed Bolad | |
| dc.date.accessioned | 2015-11-01T17:32:19Z | |
| dc.date.available | 2015-11-01T17:32:19Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Rheumatoid Arthritis (RA) is a systemic inflammatory autoimmune disorder characterized by widespread joint inflammation with synovial hyperplasia disease and the most common inflammatory arthritis, affecting from 0.5 to 1% of the general population worldwide (Gabriel, 2001). It is more common in women with female to male ratio of 2 to 4.1 (Gabriel, 1999). The peak incidence between 30 and 50 years (Ceccato et al., 2006 | en_US |
| dc.description.sponsorship | كلية الدراسات العليا -جامعة النيلين | en_US |
| dc.identifier.uri | http://hdl.handle.net/123456789/1408 | |
| dc.publisher | جامعة النيلين | en_US |
| dc.title | Rheumatoid arthritis and anti-CCP | en_US |